Describing the Sequence of Cognitive Decline in Alzheimer’s Disease Patients: Results from an Observational Study
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Improved understanding of the pattern of cognitive decline in Alzheimer's disease (AD) would be useful to assist primary care physicians in explaining AD progression to patients and caregivers. OBJECTIVE: To identify the sequence in which cognitive abilities decline in community-dwelling patients with AD. METHODS: Baseline data were analyzed from 1,495 patients diagnosed with probable AD and a Mini-Mental State Examination (MMSE) score ≤ 26 enrolled in the 18-month observational GERAS study. Proportional odds logistic regression models were applied to model MMSE subscores (orientation, registration, attention and concentration, recall, language, and drawing) and the corresponding subscores of the cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog), using MMSE total score as the index of disease progression. Probabilities of impairment start and full impairment were estimated at each MMSE total score level. RESULTS: From the estimated probabilities for each MMSE subscore as a function of the MMSE total score, the first aspect of cognition to start being impaired was recall, followed by orientation in time, attention and concentration, orientation in place, language, drawing, and registration. For full impairment in subscores, the sequence was recall, drawing, attention and concentration, orientation in time, orientation in place, registration, and language. The sequence of cognitive decline for the corresponding ADAS-cog subscores was remarkably consistent with this pattern. CONCLUSION: The sequence of cognitive decline in AD can be visualized in an animation using probability estimates for key aspects of cognition. This might be useful for clinicians to set expectations on disease progression for patients and caregivers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
The Mini‐Mental State Examination: A Comprehensive Review
Tombaugh, T. N., & McIntyre, N. J. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01992.x · Cited by 5,152 · cited 3×
“Sociodemographic variables such as age, sex, educational level, race/ethnicity, social class, and place of residence have been shown to be related to the MMSE score [5, 18], but there are conflicting reports and possible interactions between the different variables.”
BackgroundMethodInfluentialAdvancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
The Alzheimer's Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.008 · Cited by 1,525
Cognitive Phenotypes in Alzheimer's Disease and Genetic Risk
Snowden, J. S., Stopford, C. L., Julien, C. L., Thompson, J. C., Davidson, Y., Gibbons, L., Pritchard, A., Lendon, C. L., Richardson, A. M., Varma, A., et al. (2007) · Cortex · doi:10.1016/s0010-9452(08)70683-x · Cited by 254 · cited 1×
“The sequence of cognitive decline may also differ for 6–14% of patients with nonamnestic or atypical forms of AD [31], characterized by early, predominant, and progressive impairment in visuoperceptive and visuospatial function (posterior variant of AD), language (logopenic variant of AD), or behavior (frontal variant…”
BackgroundEarly onset Alzheimer’s disease is associated with a distinct neuropsychological profile
Smits, L. L., Pijnenburg, Y. A. L., Koedam, E. L. G. E., van der Vlies, A. E., Reuling, I. E. W., Koene, T., Teunissen, C. E., Scheltens, P., & van der Flier, W. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111934 · Cited by 182 · cited 1×
“[51] found that memory function was relatively well preserved in the early stages of the disease, while visuospatial functioning, executive functioning, and attention was worse in moderate AD, compared with lateonset AD patients.”
ResultPatterns of cognitive decline prior to dementia in persons with mild cognitive impairment
Cloutier, S., Chertkow, H., Kergoat, M.-J., Gauthier, S., & Belleville, S. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142910 · Cited by 124
Trajectories of Alzheimer disease‐related cognitive measures in a longitudinal sample
Bilgel, M., An, Y., Lang, A., Prince, J., Ferrucci, L., Jedynak, B., & Resnick, S. M. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.04.520 · Cited by 65 · cited 1×
“In general, our results are consistent with clinical experience and support and extend previous research on the evolution of cognitive decline over time from longitudinal studies [14, 17, 28, 29].”
ResultLong-term progression of Alzheimer's disease in patients under antidementia drugs
Gillette‐Guyonnet, S., Andrieu, S., Nourhashemi, F., Gardette, V., Coley, N., Cantet, C., Gauthier, S., Ousset, P., Vellas, B., & REAL.FR study group (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.02.009 · Cited by 64
Progression of Alzheimer disease in Europe: data from the European ICTUS study
Vellas, B., Hausner, L., Frolich, L., Cantet, C., Gardette, V., Reynish, E., Gillette, S., Aguera-Morales, E., Auriacombe, S., Boada, M., et al. (2012) · Current Alzheimer Research · doi:10.2174/156720512803251066 · Cited by 50 · cited 3×
“Second, although a decline in cognitive function is inevitable for patients with AD, the rate of cognitive decline for each patient is unknown and some longitudinal studies have indicated that it can be non-linear and highly variable [10, 11, 14, 16, 17].”
BackgroundResult
Cited by
Alzheimer’s Disease: Epidemiology and Clinical Progression
Tahami Monfared, A. A., Byrnes, M. J., White, L. A., & Zhang, Q. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00338-8 · Cited by 629
Froelich, L., Lladó, A., Khandker, R. K., Pedrós, M., Black, C. M., Sánchez Díaz, E. J., Chekani, F., & Ambegaonkar, B. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210025 · Cited by 34
The role of microRNA-485 in neurodegenerative diseases
Ryu, I. S., Kim, D. H., Cho, H.-J., & Ryu, J.-H. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0039 · Cited by 25
Metadata
- Authors
- Henneges, C., Reed, C., Chen, Y.-F., Dell’Agnello, G., & Lebrec, J.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2016-05-23
- Volume
- 52
- Issue
- 3
- Pages
- 1065-1080
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2338749872
- Cited by
- 59
- References
- 11
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Describing the Sequence of Cognitive Decline in Alzheimer’s Disease Patients: Results from an Observational Study. https://app.cochat.ai/papers/10.3233/jad-150852
- The paper
- Henneges, C., Reed, C., Chen, Y.-F., Dell’Agnello, G., & Lebrec, J. (2016). Describing the Sequence of Cognitive Decline in Alzheimer’s Disease Patients: Results from an Observational Study. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-150852
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.